MIRA INFORM REPORT
|
Report Date : |
08.02.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
C A DES MEDICAMENTS |
|
|
|
|
Formerly Known As : |
TOGOPHARMA |
|
|
|
|
Registered Office : |
BP 8349 Lome |
|
|
|
|
Country : |
Togo |
|
|
|
|
Date of Incorporation : |
15.03.2000 |
|
|
|
|
Com. Reg. No.: |
98158K Lome, Togo |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by shares |
|
|
|
|
Line of Business : |
Dealers in pharmaceuticals and related facilities |
|
|
|
|
No. of Employees
: |
35 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Togo |
c2 |
c2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
REGISTERED NAME & COMPANY
SUMMARY
|
COMPANY REPORTED: |
C A DES MEDICAMENTS |
|||
|
Actual Names: |
CAMEG - CENTRALE D'ACHAT DES MEDICAMENT ESSENTIELS ET GENERIQUES |
|||
|
Former Names: |
TOGOPHARMA |
|||
|
Principal Address: |
BP 8349 Lome, Togo |
|||
|
Telephone: |
+228-22222694/2203505 |
|||
|
Fax: |
+228-22204213/2204313 |
|||
|
Email: |
||||
|
Internet: |
||||
|
Established: |
15/03/2000 |
|||
|
Registration: |
98158K Lome, Togo |
|||
|
Legal Form: |
Limited Liability Company, Limited by shares |
|||
|
Stock Listing: |
Not Listed |
|||
|
Workforce: |
2011 |
|
|
|
|
|
35 |
|
|
|
|
Office & Factories |
|
|||
|
Head offices |
Rue De La Morgue, Quartier Tokoin Hopital, Lome, Togo |
|||
|
Branches |
Atakpamé and Kara in Togo |
|||
CREDIT RECOMENDATION
Current Credit Limit: USD 50,000
DIRECTORS/MANAGEMENT
|
Management/
Directors |
|
|
President/
CEO (1) |
|
|
Name |
Mr. Mamessile Assih |
|
Active in daily business: |
Active |
|
Current Title: |
Managing Director |
|
Country of residence |
Togo |
|
Remarks |
Top Decision Maker |
|
Director
(2) |
|
|
Name |
Mr. Takonda Pelei |
|
Active in daily business: |
Active |
|
Current Title: |
Director |
|
Country of residence |
Togo |
Þ Top decision maker is the person who has the ultimate authority or power to make important managerial decisions. He/She may or may not be officially registered as a president or an executive director.
NEGATIVE INFORMATION
Na
SHARE & SHARE CAPITAL
INFORMATION
|
Company Profile: |
|
||
|
Nominal Capital |
CFA. 10,000,000 |
||
|
Paid in Capital |
CFA. 10,000,000 |
||
|
Subscribed Capital |
CFA. 10,000,000 |
||
|
Shareholders |
|
||
|
Name |
Position |
Amount
|
Ratio |
|
Mr. Mamessile Assih |
MD |
|
|
|
Mr. Takonda Pelei |
Director |
|
|
|
Total |
|
|
100.00% |
PAYMENT INFORMATION
|
|
Terms of
payment |
|
Buying
terms |
30% in
cash, 70% on credit |
|
Selling
terms |
80% in
cash, 20% on credit |
|
Exports |
None |
|
Export
Ratio |
0.0% |
|
Import
Ratio |
Asia |
GROUP STRUCTURE & AFFILIATED
COMPANIES
|
Affiliated Companies |
None |
FINANCIAL INFORMATION
|
Recent
Sales |
CFA.
1,875,000,000 (Estimated 2011) |
FOREIGN EXCHANGE RATES
|
Exchange Rate |
US$ 1 = CFA. 503.92 |
ADDITIONAL INFORMATION
|
Business Activities |
Dealers in pharmaceuticals and related
facilities |
|
|
Terms of
payment |
|
Buying
terms |
30% in
cash, 70% on credit |
|
Selling
terms |
80% in
cash, 20% on credit |
|
|
|
|
Suppliers |
Pfizer, |
|
Customers |
Local
agencies , Hospitals, Pharmacies |
|
|
|
|
Recent
Sales |
CFA.
1,875,000,000 (Estimated 2011) |
|
Exports |
None |
|
Export
Ratio |
0.0% |
|
Import
Ratio |
Asia |
|
Domestic
Market Share |
22.0% |
|
Business Premises |
5,000 Sft |
|
Type of occupation
|
Leased |
|
Location |
The subject is located close to a major road network |
|
Premises used as
|
Offices |
|
Banking
relationship |
|
|
Main
Banks |
Eco Bank |
|
Credit Check of Subject, President & CEO (as of report date) |
|
|
Payment Morale: |
In the documents at our disposal nothing adverse has been shown so
far. |
|
CREDIT RATING: |
Financial situation is average. |
NOTES & COMMENTS
COMMENTS
Maximum credit we recommend is USD 50,000 outstanding
at any one time.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.92 |
|
UK Pound |
1 |
Rs.77.31 |
|
Euro |
1 |
Rs.64.12 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.